Doing Area Studies: Present and Future Perspectives on the History of Latin American Studies at Freie Universität Berlin

From Interest in Latin America to Contested Latin American Studies

Research on Latin America has long been a tradition in Germany and especially in Berlin, with interest dating back to Alexander von Humboldt’s expeditions (1799–1804). Early research focused on a distant region whose society and landscape, especially, were largely unknown in Germany. The aim was to explore this region and to produce new knowledge about the “other” in order to better understand the world in its complexity. From early on, decision-makers in political and economic arenas increasingly demanded detailed information about different regions of the world.

Continue reading “Doing Area Studies: Present and Future Perspectives on the History of Latin American Studies at Freie Universität Berlin”

Knowledge Notes

Relevant Publications and Newsletters

For German readers, the Themenportal “Europäische Geschichte” (18.-21. Jh.) has devoted its January newsletter to the topic of history of knowledge, with an editorial on the state of the field and its history since 1970 by Iris Schröder of the University of Erfurt, “Europäische Geschichte, Wissensgeschichte – eine Skizze.” As the H-Soz-Kult team described it (translated into English here):

Continue reading “Knowledge Notes”

Glimpses into a History of Knowledge on the Antimalarial Lariam® in Zambia

You may have heard of the antimalarial agent mefloquine during the Covid-19 pandemic, as scientists suggested repurposing the drug to combat the novel coronavirus. Most drugs are developed for the body of a 27-year-old male Caucasian, and so was this antimalarial. Mefloquine was discovered in the Antimalaria Drug Discovery Program—the biggest program of its kind—launched by the American Army in 1963. Over a period of fifteen years 250,000 antimalarial agents were tested at the Walter Reed Army Institute of Research (WRAIR) in Washington DC. In 1969, researchers discovered WR 142,490, which became known as mefloquine in 1975. While the clinical trials were conducted in malaria-endemic areas, the drug was later marketed by the Basel-based Swiss pharmaceutical company F. Hofmann-La Roche (Roche) as Lariam®.

Continue reading “Glimpses into a History of Knowledge on the Antimalarial Lariam® in Zambia”

What the History of Astronomy Can Teach Us about the Unknown

Humanity has long wished to know the universe. This desire has been present in nearly every civilization, culture, or community of human beings. Knowing the universe has always been extremely challenging, notwithstanding diverse approaches to the task—scientific reasoning, ancestral respect, the identification and worship of divinities, to name but a few. Nevertheless, there is a common gesture when we connect to the universe. No matter in what time or place, humans look up to the stars and wonder. We exhibit a common attitude as well, overwhelmed by how much we do not know about our own universe.

Continue reading “What the History of Astronomy Can Teach Us about the Unknown”

Louis Agassiz and the Classification of Brazil’s Fish

Drawing of "Sudis Pirarueú" from Agassiz et al., Selecta Genera et Species Piscium Brasiliensium, Tabula XVI.

Louis Agassiz (1807–1873) was a young student at the University of Munich when Johann von Spix and Carl Friedrich von Martius returned from their expedition to Brazil. Among the many items and specimens the German naturalists brought back were fish. The methodology they had followed on their journey through what was then part of the Portuguese Empire was typical of naturalists in the field: They observed, collected, and in some cases classified. Then, back in Europe, they studied the amassed material. Their journey through the exuberant and unfamiliar natural environment had lasted three years (1817–1820). In this geographical and temporal context, the fish and marine species were rarities that few scientists could address with authority within the framework of European natural history. The observant naturalists were nonetheless able to classify species unknown in Europe while also learning about these species’ natural environments.

Continue reading “Louis Agassiz and the Classification of Brazil’s Fish”

Debating New Approaches to Histories of the Sciences

All are invited to attend the online symposium “Debating New Approaches to Histories of the Sciences,” organized as part of the History of Knowledge Seminar Series @ Utrecht University.

Friday, May 21, 2021, 9:30–17:30 CET
Online via Microsoft Teams (registration not required)

Recent decades have seen the emergence of a number of promising new approaches to the historical study of the sciences. All share the goal of understanding scientific thinking and practice as historical phenomena, but each does so in its own distinctive way: created against different backgrounds and in response to different problem situations within and outside academia they orient themselves around different themes, topics and perspectives. This raises the issue of whether and if so, how, these approaches could best collaborate.

Continue reading “Debating New Approaches to Histories of the Sciences”

Learning by the Book: Manuals and Handbooks in the History of Science

How do practitioners—of any form of specialized knowledge—learn technical skills, and how do they find knowledge deemed solid and secure? Clearly, much training occurs within formal situations such as schools and laboratories. Classrooms and their textbooks have attracted due attention from historians, with a focus in the last decade or so on how teachers convey working knowledge bodily and not only abstractly to their students or apprentices. But learning does not stop with formal education, and often enough it starts elsewhere. Manuals and handbooks have long enabled informal, often self-directed education and training. They also provide a new vantage point for bringing together history of science with history of books and media, from antiquity to the present. These instructional texts and compendia codify the knowledge of a working community with an eye to communicating what a new practitioner needs to know. Such texts have also played a key role in bringing local knowledge and know-how to far-flung readers and practitioners around the globe. By following these apparently mundane texts and their uses, rather than focusing only on elite practitioners, we bring into view an exciting new set of historical connections and participants.

Continue reading “Learning by the Book: Manuals and Handbooks in the History of Science”

Swedish Science and European French

Eighteenth-century Sweden was a scientific powerhouse. Its researchers gave their names to some of the most significant developments of the period, from the Linnaean system of binomial classification to the temperature metric established by Anders Celsius. But what if I told you that one secret to Sweden’s success was a German-speaking Protestant from Alsace?

Continue reading “Swedish Science and European French”

Public and Scientific Uncertainty in the Time of COVID-19

As historian of science Lorraine Daston recently remarked, COVID-19 has thrown us back into a state of “ground-zero empiricism.” The manifold manifestations of COVID-19 and the many unknowns involved are provoking scientific speculation that is often based on nothing more than chance observations and personal anecdotes. The radical uncertainty of the current situation, writes Daston, has catapulted us back to the seventeenth century, with almost everything up for grabs, “just as it was for the members of the earliest scientific societies—and everyone else—circa 1660.”1

Continue reading “Public and Scientific Uncertainty in the Time of COVID-19”

CfP: Global Knowledge, Global Legitimacy? Transatlantic Biomedicine since 1970

Washington, DC, Sept. 6-7, 2019
Application deadine: Dec. 15, 2018

When the French pharmaceutical company Roussell Uclaff, a subsidiary of the German chemical giant Hoechst AG, was ready to introduce an abortion pill in 1988, American activists flooded the company’s headquarters near Frankfurt with protest letters. In response, the company’s German CEO mandated to stop the project. But the French state, a Hoechst minority shareholder, took the idea across the border, patented it, and embarked on medical trials for the new product in France. Ten years later, scientists in the United States successfully isolated human embryonic stem cells. The country’s regulatory framework had left them free to let the cells proliferate indefinitely. But researchers adopted concepts implemented in Britain to limit the cells’ growth to 13 days after gestation.

Continue reading→